Gottlieb Has Contacted Intermediaries Over Restricted Distribution Schemes, But No Changes Have Occurred

May 15, 2018
FDA Commissioner Scott Gottlieb has fulfilled his promise to contact supply chain intermediaries and discourage them from entering into so-called voluntary restricted distribution systems that block generic companies from buying samples needed for FDA-required testing, however his pressure to date has not been successful. The practice of brand companies signing contracts with distributors that bar the intermediaries’ ability to sell samples to generic companies has come to light in the past year. The House oversight committee held a hearing on...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.